Literature DB >> 16794017

Cardiopulmonary resuscitation in a rat model of chronic myocardial ischemia.

Xiangshao Fang1, Wanchun Tang, Shijie Sun, Lei Huang, Yun-Te Chang, Zitong Huang, Max Harry Weil.   

Abstract

Our group has developed a rat model of cardiac arrest and cardiopulmonary resuscitation (CPR). However, the current rat model uses healthy adult animals. In an effort to more closely reproduce the event of cardiac arrest and CPR in humans with chronic coronary disease, a rat model of coronary artery constriction was investigated during cardiac arrest and CPR. Left coronary artery constriction was induced surgically in anesthetized, mechanically ventilated Sprague-Dawley rats. Echocardiography was used to measure global cardiac performance before surgery and 4 wk postsurgery. Coronary constriction provoked significant decreases in ejection fraction, increases in left ventricular end-diastolic volume, and increases left ventricular end-systolic volume at 4 wk postintervention, just before induction of ventricular fibrillation (VF). After 6 min of untreated VF, CPR was initiated on three groups: 1) coronary artery constriction group, 2) sham-operated group, and 3) control group (without preceding surgery). Defibrillation was attempted after 6 min of CPR. All the animals were resuscitated. Postresuscitation myocardial function as measured by rate of left ventricular pressure increase at 40 mmHg and the rate of left ventricular pressure decline was more significantly impaired and left ventricular end-diastolic pressure was greater in the coronary artery constriction group compared with the sham-operated group and the control group. There were no differences in the total shock energy required for successful resuscitation and duration of survival among the groups. In summary, this rat model of chronic myocardial ischemia was associated with ventricular remodeling and left ventricular myocardial dysfunction 4 wk postintervention and subsequently with severe postresuscitation myocardial dysfunction. This model would suggest further clinically relevant investigation on cardiac arrest and CPR.

Entities:  

Mesh:

Year:  2006        PMID: 16794017     DOI: 10.1152/japplphysiol.01487.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique.

Authors:  Lorissa Lamoureux; Jeejabai Radhakrishnan; Raúl J Gazmuri
Journal:  J Vis Exp       Date:  2015-04-26       Impact factor: 1.355

2.  The effects of lazaroid U-74389G in a rat sepsis model.

Authors:  Yun-Te Chang; Shue-Ren Wann; Kai-Hseng Hsieh; Yung-Ching Liu; Ching-Hsiung Chang; Mu-Shun Huang; Chun-I Huang; Hong-Tai Chang
Journal:  Inflamm Res       Date:  2010-07-11       Impact factor: 4.575

3.  Chronic health conditions and survival after out-of-hospital ventricular fibrillation cardiac arrest.

Authors:  Heather T Carew; Weiya Zhang; Thomas D Rea
Journal:  Heart       Date:  2007-02-19       Impact factor: 5.994

4.  Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicin.

Authors:  Keld Fosgerau; Giuseppe Ristagno; Magdalena Jayatissa; Mads Axelsen; Jacob W Gotfredsen; Uno J Weber; Lars Køber; Christian Torp-Pedersen; Charlotte Videbaek
Journal:  BMC Cardiovasc Disord       Date:  2010-08-31       Impact factor: 2.298

5.  Outcome of prolonged ventricular fibrillation and CPR in a rat model of chronic ischemic left ventricular dysfunction.

Authors:  Xiangshao Fang; Lei Huang; Shijie Sun; Max Harry Weil; Wanchun Tang
Journal:  Biomed Res Int       Date:  2013-12-17       Impact factor: 3.411

6.  Gene Expressions Underlying Mishandled Calcium Clearance and Elevated Generation of Reactive Oxygen Species in the Coronary Artery Smooth Muscle Cells of Chronic Heart Failure Rats.

Authors:  Liang Ding; Xian-Xiu Su; Wen-Hui Zhang; Yu-Xiang Xu; Xue-Feng Pan
Journal:  Chin Med J (Engl)       Date:  2017-02-20       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.